Is Johnson & Johnson a good investment? Johnson & Johnson (JNJ.DE) is currently trading at 212.55 EUR.
In terms of valuation, the stock trades at a P/E ratio of 21.93. This valuation is generally in line with the broader market.
Earnings Schedule: Johnson & Johnson is expected to release its next earnings report on April 14, 2026.
For income investors, Johnson & Johnson pays a dividend yield of 2.14%. With a payout ratio of 46%, the dividend appears sustainable.
Yes, it pays an annual dividend of 5.20 EUR (2.14% yield).
Johnson & Johnson is classified as a Stock. You can compare it against 14 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be April 14, 2026. The company currently has a trailing EPS of 9.57.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
2.14% (5y avg: 2.76%)
5.20 EUR
Feb. 24, 2026
46.19%
| Year | Total Dividends |
|---|---|
| 2027 | 1.17 EUR |
| March 9, 2027 (estimated) | 1.1683 |
| 2026 | 4.63 EUR |
| Dec. 8, 2026 (estimated) | 1.1830 |
| Sept. 8, 2026 (estimated) | 1.1765 |
| June 9, 2026 (estimated) | 1.1652 |
| March 10, 2026 | 1.1043 |
| 2025 | 4.44 EUR |
| Dec. 9, 2025 | 1.1238 |
| Sept. 9, 2025 | 1.1176 |
| June 10, 2025 | 1.1070 |
| March 4, 2025 | 1.0902 |
| 2024 | 4.91 EUR |
| Dec. 10, 2024 | 1.2400 |
| Sept. 10, 2024 | 1.2400 |
| June 4, 2024 | 1.2400 |
| March 5, 2024 | 1.1900 |
| 2023 | 4.70 EUR |
| Dec. 5, 2023 | 1.1900 |
| Sept. 7, 2023 | 1.1900 |
| June 6, 2023 | 1.1900 |
| March 7, 2023 | 1.1300 |
| 2022 | 4.45 EUR |
| Dec. 6, 2022 | 1.1300 |
| Sept. 6, 2022 | 1.1300 |
| June 7, 2022 | 1.1300 |
| March 8, 2022 | 1.0600 |
| 2021 | 4.19 EUR |
| Dec. 7, 2021 | 1.0600 |
| Sept. 7, 2021 | 1.0600 |
| June 8, 2021 | 1.0600 |
| March 9, 2021 | 1.0100 |
| 2020 | 3.98 EUR |
| Dec. 8, 2020 | 1.0100 |
| Sept. 8, 2020 | 1.0100 |
| June 9, 2020 | 1.0100 |
| March 10, 2020 | 0.9500 |
| 2019 | 3.75 EUR |
| Dec. 10, 2019 | 0.9500 |
| Sept. 10, 2019 | 0.9500 |
| June 11, 2019 | 0.9500 |
| March 12, 2019 | 0.9000 |
| 2018 | 3.54 EUR |
| Dec. 11, 2018 | 0.9000 |
| Sept. 11, 2018 | 0.9000 |
| June 12, 2018 | 0.9000 |
| March 13, 2018 | 0.8400 |
| 2017 | 3.32 EUR |
| Dec. 12, 2017 | 0.8400 |
| Sept. 12, 2017 | 0.8400 |
| June 13, 2017 | 0.8400 |
| March 14, 2017 | 0.8000 |
| 2016 | 3.15 EUR |
| Dec. 6, 2016 | 0.8000 |
| Sept. 6, 2016 | 0.8000 |
| June 7, 2016 | 0.8000 |
| March 8, 2016 | 0.7500 |
| 2015 | 2.95 EUR |
| Dec. 8, 2015 | 0.7500 |
| Sept. 8, 2015 | 0.7500 |
| June 9, 2015 | 0.7500 |
| March 10, 2015 | 0.7000 |
| 2014 | 2.76 EUR |
| Dec. 9, 2014 | 0.7000 |
| Sept. 9, 2014 | 0.7000 |
| June 10, 2014 | 0.7000 |
| March 11, 2014 | 0.6600 |
| 2013 | 2.59 EUR |
| Dec. 10, 2013 | 0.6600 |
| Sept. 10, 2013 | 0.6600 |
| June 11, 2013 | 0.6600 |
| March 12, 2013 | 0.6100 |
| 2012 | 2.40 EUR |
| Dec. 11, 2012 | 0.6100 |
| Sept. 11, 2012 | 0.6100 |
| June 12, 2012 | 0.6100 |
| March 13, 2012 | 0.5700 |
| 2011 | 2.25 EUR |
| Dec. 13, 2011 | 0.5700 |
| Sept. 13, 2011 | 0.5700 |
| June 14, 2011 | 0.5700 |
| March 15, 2011 | 0.5400 |
| 2010 | 2.11 EUR |
| Dec. 14, 2010 | 0.5400 |
| Sept. 14, 2010 | 0.5400 |
| June 15, 2010 | 0.5400 |
| March 9, 2010 | 0.4900 |
| 2009 | 6.93 EUR |
| Dec. 8, 2009 | 0.4900 |
| Sept. 8, 2009 | 0.4900 |
| June 9, 2009 | 0.4900 |
| March 26, 2009 | 5.0000 |
| March 10, 2009 | 0.4600 |
| 2008 | 4.30 EUR |
| Dec. 9, 2008 | 0.4600 |
| Sept. 25, 2008 | 2.5000 |
| Sept. 9, 2008 | 0.4600 |
| June 10, 2008 | 0.4600 |
| March 11, 2008 | 0.4150 |
Yearly aggregated dividends
|
Johnson & Johnson
Mar 10, 2026 Paid
Dividend
1.10433 EUR |
|
Johnson & Johnson
Dec 09, 2025 Paid
Dividend
1.12384 EUR |
|
Johnson & Johnson
Sep 09, 2025 Paid
Dividend
1.11761 EUR |
|
Johnson & Johnson
Jun 10, 2025 Paid
Dividend
1.10695 EUR |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion